Clinical trials
Completed Phase 1 trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 37 |
| AbbVie | 7 |
| Gilead Sciences | 7 |
| Children's Oncology Group | 6 |
| Eli Lilly and Company | 5 |
| AbbVie (prior sponsor, Abbott) | 3 |
| Bristol-Myers Squibb | 3 |
| University of Puerto Rico | 3 |
| GlaxoSmithKline | 2 |
| Hoffmann-La Roche | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 37 |
| Acquired Immunodeficiency Syndrome | 15 |
| Hepatitis C | 15 |
| AIDS-Related Complex | 12 |
| Hepatitis C, Chronic | 7 |
| Pregnancy Complications, Infectious | 5 |
| Brain Neoplasms | 4 |
| Zika Virus Infection | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Central Nervous System Neoplasms | 3 |
Trials
Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.